Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stem Cells | 6 | 2023 | 33 | 0.950 |
Why?
|
| Barrett Esophagus | 3 | 2020 | 5 | 0.750 |
Why?
|
| Esophageal Neoplasms | 2 | 2020 | 4 | 0.630 |
Why?
|
| Lung | 4 | 2023 | 35 | 0.580 |
Why?
|
| Adenocarcinoma | 2 | 2022 | 10 | 0.520 |
Why?
|
| Cell Culture Techniques | 2 | 2020 | 24 | 0.480 |
Why?
|
| Neoplasms | 2 | 2024 | 90 | 0.470 |
Why?
|
| Esophagus | 2 | 2019 | 5 | 0.430 |
Why?
|
| Antineoplastic Agents | 3 | 2024 | 69 | 0.410 |
Why?
|
| Molecular Targeted Therapy | 3 | 2024 | 35 | 0.380 |
Why?
|
| Humans | 16 | 2024 | 4936 | 0.370 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2023 | 10 | 0.370 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2024 | 26 | 0.360 |
Why?
|
| Neuroblastoma | 2 | 2020 | 12 | 0.330 |
Why?
|
| Esophagitis, Peptic | 1 | 2020 | 2 | 0.330 |
Why?
|
| Regenerative Medicine | 1 | 2020 | 4 | 0.330 |
Why?
|
| Epithelial Cells | 1 | 2020 | 31 | 0.320 |
Why?
|
| Gastric Acid | 1 | 2019 | 2 | 0.310 |
Why?
|
| Oocytes | 1 | 2018 | 1 | 0.280 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 10 | 0.280 |
Why?
|
| Transcription Factors | 1 | 2018 | 66 | 0.270 |
Why?
|
| Animals | 9 | 2024 | 1711 | 0.260 |
Why?
|
| Carcinoma in Situ | 1 | 2016 | 1 | 0.240 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2016 | 1 | 0.240 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 1 | 0.240 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2016 | 2 | 0.240 |
Why?
|
| Neoplastic Stem Cells | 1 | 2016 | 6 | 0.240 |
Why?
|
| Mice | 6 | 2023 | 685 | 0.230 |
Why?
|
| Cystic Fibrosis | 1 | 2023 | 6 | 0.210 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2023 | 2 | 0.200 |
Why?
|
| Stomach Neoplasms | 1 | 2022 | 2 | 0.190 |
Why?
|
| Pneumonia | 2 | 2020 | 20 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 29 | 0.160 |
Why?
|
| Adult Stem Cells | 1 | 2020 | 3 | 0.160 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 55 | 0.160 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 26 | 0.160 |
Why?
|
| Period Circadian Proteins | 1 | 2019 | 5 | 0.150 |
Why?
|
| Circadian Clocks | 1 | 2019 | 4 | 0.150 |
Why?
|
| Iron Overload | 1 | 2019 | 4 | 0.150 |
Why?
|
| Anemia, Sickle Cell | 1 | 2019 | 10 | 0.150 |
Why?
|
| Metaplasia | 3 | 2020 | 6 | 0.150 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 34 | 0.150 |
Why?
|
| Female | 4 | 2020 | 2523 | 0.140 |
Why?
|
| Gastroenterology | 1 | 2017 | 1 | 0.130 |
Why?
|
| Stomach | 1 | 2017 | 1 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2017 | 4 | 0.130 |
Why?
|
| Biomedical Research | 1 | 2017 | 10 | 0.130 |
Why?
|
| Tumor Microenvironment | 2 | 2022 | 27 | 0.120 |
Why?
|
| Cells, Cultured | 2 | 2020 | 127 | 0.110 |
Why?
|
| Inflammation | 2 | 2023 | 57 | 0.090 |
Why?
|
| Male | 3 | 2020 | 2491 | 0.090 |
Why?
|
| Clone Cells | 1 | 2020 | 4 | 0.080 |
Why?
|
| RNA, Small Interfering | 1 | 2020 | 35 | 0.080 |
Why?
|
| Keratin-5 | 1 | 2019 | 2 | 0.080 |
Why?
|
| Carcinogenesis | 1 | 2019 | 9 | 0.080 |
Why?
|
| Cyclooxygenase 2 | 1 | 2019 | 7 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2019 | 11 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 13 | 0.070 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2018 | 1 | 0.070 |
Why?
|
| DNA Damage | 1 | 2018 | 9 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 15 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2016 | 13 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2023 | 2 | 0.050 |
Why?
|
| Myofibroblasts | 1 | 2023 | 6 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2023 | 9 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2023 | 12 | 0.050 |
Why?
|
| SOX9 Transcription Factor | 1 | 2022 | 2 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2023 | 180 | 0.050 |
Why?
|
| Immunosuppressive Agents | 1 | 2022 | 19 | 0.050 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2020 | 2 | 0.040 |
Why?
|
| 3T3 Cells | 1 | 2020 | 2 | 0.040 |
Why?
|
| Biopsy | 1 | 2020 | 13 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 12 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 15 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 23 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2019 | 2 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 48 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 216 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2019 | 140 | 0.040 |
Why?
|
| Societies, Medical | 1 | 2017 | 7 | 0.030 |
Why?
|
| Child | 1 | 2020 | 627 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 15 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 60 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 67 | 0.030 |
Why?
|
| Aged | 1 | 2020 | 703 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 159 | 0.030 |
Why?
|
| Precancerous Conditions | 1 | 2016 | 3 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 9 | 0.030 |
Why?
|
| Middle Aged | 1 | 2020 | 967 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2016 | 71 | 0.030 |
Why?
|
| Mutation | 1 | 2016 | 132 | 0.030 |
Why?
|
| United States | 1 | 2017 | 495 | 0.030 |
Why?
|
| Adult | 1 | 2020 | 1567 | 0.030 |
Why?
|